AlzeCure Pharma AB
Share:
Subscribe:

news.cision.com/
AlzeCure Pharma AB/
Positive data from the clinical phase I MAD study with AlzeCure's Alzheimer's project NeuroRestore ACD856/
Martin Jönsson CEO AlzeCure Pharma

Martin Jönsson CEO AlzeCure Pharma

Wed, Jun 29, 2022 13:00 CET

Medium resolution

Original resolution

Subscribe

©Cision

Privacy statement | Cookies | About | Content Policy | Contact

©Cision Privacy statement Cookies About Content Policy Contact